These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1389293)

  • 1. [Agranulocytosis caused by ticlopidine].
    del Rey Moreno J; López Cortés LF; Gómez Mateos JM; Lozano de León F
    Neurologia; 1992 May; 7(5):121-2. PubMed ID: 1389293
    [No Abstract]   [Full Text] [Related]  

  • 2. Necrotizing gingivitis: a possible oral manifestation of ticlopidine-induced agranulocytosis.
    Rajandram RK; Ramli R; Karim F; Rahman RA; Fun LC
    N Z Med J; 2007 Jun; 120(1256):U2590. PubMed ID: 17589558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Agranulocytosis caused by ticlopidine].
    Legarra G; Beltrán de Heredia JM; Olabarría I; Menoyo MV; Villarreal JJ
    Sangre (Barc); 1994 Jun; 39(3):229-30. PubMed ID: 7524171
    [No Abstract]   [Full Text] [Related]  

  • 4. Agranulocytosis associated with ticlopidine: a possible benefit with filgastim.
    Marinella MA
    Ann Clin Lab Sci; 1997; 27(6):418-21. PubMed ID: 9433539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ticlopidine-induced pancytopenia: therapy of agranulocytosis with granulocyte colony stimulating factor].
    Schneider AW; Fechler L; Gilfrich HJ
    Med Klin (Munich); 1996 Jun; 91(6):417-9. PubMed ID: 8767319
    [No Abstract]   [Full Text] [Related]  

  • 6. [Agranulocytosis during a treatment with nitrendipine and ticlopidine].
    Lagier C; Vial T; Rabilloud M; Evreux JC
    Therapie; 1991; 46(2):169-70. PubMed ID: 2053096
    [No Abstract]   [Full Text] [Related]  

  • 7. [Adverse hematologic effects of ticlopidine].
    Lesesve JF; Noblet C; Stamatoullas A; Gueit I; Moore N; Monconduit M
    Therapie; 1995; 50(5):468-70. PubMed ID: 8571290
    [No Abstract]   [Full Text] [Related]  

  • 8. [Mainly neutropenic pancytopenia caused by acute bone marrow depression during ticlopidine treatment].
    Montanari G; Mussida M; Scarabelli C; Zinzalini G
    Clin Ter; 1987 Oct; 123(2):111-4. PubMed ID: 2972472
    [No Abstract]   [Full Text] [Related]  

  • 9. [Agranulocytosis caused by ticlopidine].
    Marmont AM; Lotti G; Nati S; Martinengo M; Morgano A
    Recenti Prog Med; 1985 May; 76(5):245-8. PubMed ID: 4023387
    [No Abstract]   [Full Text] [Related]  

  • 10. [Drug-induced agranulocytosis: clinical study of 19 cases].
    Márquez JA; Pardo C; Amutio E; Cortés C; Piñán MA; Alvarez C
    Sangre (Barc); 1998 Oct; 43(5):436-8. PubMed ID: 9868339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agranulocytosis caused by ticlopidine and its mechanism.
    Ono K; Kurohara K; Yoshihara M; Shimamoto Y; Yamaguchi M
    Am J Hematol; 1991 Aug; 37(4):239-42. PubMed ID: 1858780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of ticlopidine by activated neutrophils: implications for ticlopidine-induced agranulocytosis.
    Liu ZC; Uetrecht JP
    Drug Metab Dispos; 2000 Jul; 28(7):726-30. PubMed ID: 10859143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of ischemic stroke.
    Shear NH; Appel C
    N Engl J Med; 1995 Aug; 333(7):460. PubMed ID: 7617005
    [No Abstract]   [Full Text] [Related]  

  • 14. Rapid improvement of psoriasis vulgaris during drug-induced agranulocytosis.
    Toichi E; Tachibana T; Furukawa F
    J Am Acad Dermatol; 2000 Aug; 43(2 Pt 2):391-5. PubMed ID: 10901732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comment: Pseudomonas bacteremia secondary to ticlopidine-induced agranulocytosis.
    Johanning RJ; Tschida SJ
    Ann Pharmacother; 1996 Oct; 30(10):1201. PubMed ID: 8893137
    [No Abstract]   [Full Text] [Related]  

  • 16. Hematological toxicity of ticlopidine.
    Lesesve JF; Callat MP; Lenormand B; Monconduit M; Noblet C; Moore N; Caron F; Humbert G; Stamatoullas A; Tilly H
    Am J Hematol; 1994 Oct; 47(2):149-50. PubMed ID: 8092140
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hematological toxicity of ticlopidine? (author's transl)].
    de Gramont A; Canuel C; Krulik M; Bauters F; Degos L; Marty M; Najean Y
    Nouv Rev Fr Hematol (1978); 1982; 24(1):35-7. PubMed ID: 7071010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive aspergillosis in a patient with ticlopidine-induced agranulocytosis.
    Rimbrot S; Kundzinsh E; Levy Y
    Arch Intern Med; 2000 Dec 11-25; 160(22):3498-9. PubMed ID: 11112250
    [No Abstract]   [Full Text] [Related]  

  • 19. [Ticlopidine and bone marrow aplasia].
    Sánchez Ayuso J; Fernández González F; Fernández Rodríguez E
    Med Clin (Barc); 1997 Nov; 109(16):649. PubMed ID: 9463147
    [No Abstract]   [Full Text] [Related]  

  • 20. [Agranulocytosis and ticlopidine].
    Fernández Esteban V; Cuevas Ruiz B; Cuevas Ruiz MV; Saralegui Reta I; Ochoa Gómez J
    An Med Interna; 2001 May; 18(5):281-2. PubMed ID: 11496567
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.